FDA Drug recall D-0246-2019
Zero Xtreme Dietary Supplement 30-count capsules
- FDA Drug
- Class II
- terminated
- Published 2018-11-21
On 2018-11-21 the FDA classified a Class II recall of Zero Xtreme Dietary Supplement 30-count capsules by Zero Xtreme Usa, citing marketed Without an Approved NDA/ANDA: Undeclared Sibutramine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0246-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-10-15 |
| Published | 2018-11-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Zero Xtreme Usa |
| Distribution | US |
Product
Zero Xtreme Dietary Supplement 30-count capsules. By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USA
Reason
Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine
Identifiers
| code_info | Lot: 1220062085 Exp. 03/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0246-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.